Sun Pharma’s formulation sales in the US were at $477 million, marginally up by 0.6% from the previous year, the company said. US sales accounted for approximately 27.5% of its total consolidated sales.
Sun Pharma’s formulation sales in the US were at $477 million, marginally up by 0.6% from the previous year, the company said. US sales accounted for approximately 27.5% of its total consolidated sales.